Information Journal Paper
APA:
Copy. (2020). Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. LANCET, 395(10237), 1613-1626. SID. https://sid.ir/paper/692363/en
Vancouver:
Copy. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. LANCET[Internet]. 2020;395(10237):1613-1626. Available from: https://sid.ir/paper/692363/en
IEEE:
Copy, “Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial,” LANCET, vol. 395, no. 10237, pp. 1613–1626, 2020, [Online]. Available: https://sid.ir/paper/692363/en